BioPerfectus is proud to introduce Thirteen more new members for Zoonotic Infectious Diseases Total PCR Solution, providing our partners with verified products and rapid response to a global health emergency.

BioPerfectus joins the global community in celebrating the progress made toward gender equity and recommitting to advancing the empowerment of women everywhere. This year's theme is Embrace Equity to get the world talking about Why equal opportunities aren't enough. People start from different places, so true inclusion and belonging require equitable action.

BioPerfectus is a leading global company in the molecular diagnostics market, with a presence in over 100 countries worldwide. Today, we will take a closer look at BioPerfectus' market footprint in Thailand and how it has empowered end-users to provide diagnostic solutions.

The World Health Organization (WHO) officially declared Equatorial Guinea's first-ever outbreak of Marburg disease on Feb. 13, saying the virus is responsible for at least nine deaths in the tiny Western African country.Here’s what we need to know about the deadly virus and the disease it causes.

BioPerfectus was recently certified as the Export Commodity Brand by the CCPIT (China Council for the Promotion of International Trade). The quality of BioPerfectus Molecular diagnostic products has been officially recognized by the CCPIT.

BioPerfectus is proud to launch four new PCR products: Mycoplasma Genitalium Real Time PCR Kit, Herpes Simplex Virus Real Time PCR Kit, Trichomonas Vaginalis Real Time PCR Kit and Respiratory Virus Panel (7) Real Time PCR Kit.

BioPerfectus will start the next "golden decade" with a new attitude and adopt a more international logo in a broader commercial market. We aim to create a stronger image that would build on the previous one and accurately describe who we are today: one of the global IVD suppliers with a mission to embrace the world with health.

A batch of Bioperfectus-developed Nucleic Acid Extraction System SSNP-2000B began shipping today to World Health Organization (WHO). The distribution of Bioperfectus SSNP-2000B Nucleic Acid Extraction System will support the development of molecular diagnostics in Africa.

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.